Upcoming Events.


March 29th 2023 - April 1st 2023

European Lung Cancer Congress 2023

Copenhagen, Denmark

May 11th 2023 - May 13th 2023

ESMO Breast Cancer 2023

Berlin, Germany

May 16th 2023 - May 17th 2023

BIONNALE 2023

Marc Voigt, CEO of Immutep will participate in the upcoming event

June 2nd 2023 - June 6th 2023

ASCO 2023 Annual Meeting

McCormick Place, Chicago, IL, USA and Online

Past Events.


March 20th 2023 - March 22nd 2023

BIO-EUROPE SPRING

Basel, Switzerland

February 17th 2023

ShareCafe Webinar

Marc Voigt, CEO of Immutep will participate in the upcoming virtual event and will deliver a presentation.

Speaking time of Marc Voigt: 12:30 pm AEDT on Friday, 17 February 2023

Link to the Presentation

January 9th 2023 - January 12th 2023

J.P. Morgan 41st Annual Healthcare Conference

Marc Voigt, CEO and Deanne Miller, COO will be attending and hosting meetings at the 41st Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023 at the Westin St. Francis in San Francisco, CA. 

December 5th 2022 - December 6th 2022

The JMP Securities Hematology and Oncology Summit

Marc Voigt, CEO of Immutep will participate in the event virtually and will deliver a corporate presentation.

Speaking time of Marc Voigt: 11:20 AM ET on Wednesday, 7 December 2022

Link to the webcast

November 23rd 2022 - March 21st 2023

Annual General Meeting 2022

Immutep Annual General Meeting 2022 will be taking place at Offices of Piper Alderman, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW on Wednesday, 23 November 2022, 11.00 am (AEDT)

Notice of Meeting

November 14th 2022 - November 16th 2022

13th Annual Jefferies London Healthcare Conference

Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference

Speaking time of Marc Voigt: 1:30pm - 2.00pm (UTC) on Thursday, 17 November 2022

A replay of the webcast is available here

For questions, please email londonhealthcareconf@jefferies.com 

November 8th 2022 - November 12th 2022

SITC - 37th Annual Meeting & Pre-Conference Programs 2022

The company will participate in the upcoming in-person conference.

Venue: Boston, MA

https://ascopost.com/videos/sitc-2022/wade-iams-on-nsclc-combining-an-antigen-presenting-cell-activator-with-pembrolizumab/

November 7th 2022 - November 9th 2022

Bell Potter Healthcare Conference 2022

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming virtual conference and will deliver a presentation.

Speaking time of Marc Voigt: 10:00am - 10:30am (AEDT) on Wednesday, 9 November 2022 

September 29th 2022

Ladenburg Thalmann's 2022 Healthcare Conference

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming conference to present a corporate overview

Link to Webcast

September 28th 2022 - March 21st 2023

Cantor Oncology, Hematology & HemeOnc Conference

Marc Voigt, CEO and Deanne Miller, COO will participate in the in-person conference 

September 20th 2022 - September 22nd 2022

Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit

Immutep will participate in the 2nd Non-Small Cell Lung Cancer Drug Development Summit

Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:

A Soluble LAG-3 Protein (Eftilagimod Alpha) with an Anti-PD-1 Antibody (Pembrolizumab): Results of a Phase II Study in NSCLC

Speaking time of Frederic Triebel: 12.00 EST, Thursday 22nd September 2022

Click here for the Presentation

Click here for the Event Guide

September 13th 2022 - September 16th 2022

CLSA 29th Annual CITIC CLSA Flagship Investors' Forum

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the virtual Investor' Forum

September 6th 2022 - September 7th 2022

E&P’s Inaugural Small Caps Health Care Conference

Marc Voigt, CEO of Immutep will participate in the conference virtually and Deanne Miller, COO will participate in person.

Speaking time of Marc Voigt: 15:50 pm – 16:20 pm AEST on Tuesday, 6 September 2022

August 6th 2022 - August 9th 2022

2022 World Conference on Lung Cancer

Immutep will attend to the 2022 World Conference on Lung Cancer.

June 8th 2022 - June 10th 2022

Jefferies Global Healthcare Conference

Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference and will be available for one to one investor meetings in New York City on June 8-10, 2022.

Speaking time of Marc Voigt: 8:30 AM ET on 10 June, 2022

June 3rd 2022 - June 7th 2022

ASCO 2022 Annual Meeting

Venue: McCormick Place, Chicago, IL, USA

May 26th 2022

Wilsons Rapid Insights

Marc Voigt, CEO and Deanne Miller, COO will participate in the in-person conference and deliver 45-minute small group briefings with Q&A.

May 26th 2022 - May 27th 2022

Jefferies Australia MedTech/Biotech Summit

Marc Voigt, CEO of Immutep will participate in the upcoming virtual event and will deliver a presentation.

Speaking time of Marc Voigt: 9.00 am AEST on Friday 27 May, 2022

May 11th 2022 - May 12th 2022

BIONNALE 2022

Immutep will participate in this year`s event.

May 3rd 2022 - May 5th 2022

ESMO Breast Cancer Congress 2022

Immutep will attend to the ESMO Breast Cancer Congress 2022.

 

April 28th 2022 - April 29th 2022

Goldman Sachs 6th Small/Mid-Cap Healthcare Day

The conference will be a virtual format and involve an informal panel discussion followed by Q&A from the audience.

To join the live event, please contact your Goldman Sach’s representative.

Speaking time of Marc Voigt/ CEO: 3:45pm AEST on 29th April

April 4th 2022 - April 6th 2022

BIO - Europe Spring

Marc Voigt, CEO of Immutep will participate in the upcoming digital event.

March 30th 2022 - April 2nd 2022

European Lung Cancer Congress 2022

Immutep is presenting new data at the European Lung Cancer Congress 2022.

March 28th 2022 - March 30th 2022

Maxim Growth Conference

CEO Marc Voigt will participate in a fireside chat plus corporate presentation.
Fireside chat time & date: 11:00 am Eastern Daylight Time (EDT) on Monday 28 March 2022.